A quantitative immunoassay for lung cancer biomarker CIZ1b in patient plasma

OBJECTIVES: Non-invasive tests for early detection of lung cancer are an important unmet clinical need. CIZ1b plasma biomarker can discriminate stage 1 lung cancer from within high-risk groups with clinically useful accuracy, with ROC AUCs in excess of 0.9 for two independent retrospective cohorts,...

Descripción completa

Detalles Bibliográficos
Autores principales: Coverley, Dawn, Higgins, Gillian, West, Daniel, Jackson, Oliver T., Dowle, Adam, Haslam, Aidan, Ainscough, Eve, Chalkley, Rebecca, White, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441127/
https://www.ncbi.nlm.nih.gov/pubmed/27867087
http://dx.doi.org/10.1016/j.clinbiochem.2016.11.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441127/
https://www.ncbi.nlm.nih.gov/pubmed/27867087
http://dx.doi.org/10.1016/j.clinbiochem.2016.11.015

Ejemplares similares